Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 11 , Pages 1452-1464, November 2007

Exercise Therapy and Other Types of Physical Therapy for Patients With Neuromuscular Diseases: A Systematic Review

  • Edith H. Cup, MSc, OT

      Affiliations

    • Department of Occupational Therapy, Research Centre of Allied Health Care, Nijmegen, The Netherlands
    • Corresponding Author InformationReprint requests to Edith H. Cup, MSc, OT, Radboud University Nijmegen Medical Centre, Rehabilitation/Allied Health Care 897, PO Box 9101, 6500 HB Nijmegen, The Netherlands
    • ,
  • Allan J. Pieterse, PT

      Affiliations

    • Department of Physical Therapy, Research Centre of Allied Health Care, Nijmegen, The Netherlands
    • ,
  • Jessica M. ten Broek-Pastoor, MSc, PT

      Affiliations

    • Department of Physical Therapy, Research Centre of Allied Health Care, Nijmegen, The Netherlands
    • ,
  • Marten Munneke, PhD, PT

      Affiliations

    • Institute of Neurology, Department of Physical Therapy, Research Centre of Allied Health Care, Nijmegen, The Netherlands
    • ,
  • Baziel G. van Engelen, MD, PhD

      Affiliations

    • Institute of Neurology, Neuromuscular Centre Nijmegen, Nijmegen, The Netherlands
    • ,
  • Henk T. Hendricks, MD, PhD

      Affiliations

    • Department of Rehabilitation Medicine, Biostatistics and Health Technology Assessment, Nijmegen, The Netherlands
    • ,
  • Gert J. van der Wilt, PhD

      Affiliations

    • Department of Epidemiology, Biostatistics and Health Technology Assessment, Nijmegen, The Netherlands
    • ,
  • Rob A. Oostendorp, PhD, PT

      Affiliations

    • Centre for Quality of Care Research (WOK), Research Centre of Allied Health Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • Dutch Institute of Allied Health Care, Amersfoort, The Netherlands.

Article Outline

Abstract 

Cup EH, Pieterse AJ, ten Broek-Pastoor JM, Munneke M, van Engelen BG, Hendricks HT, van der Wilt GJ, Oostendorp RA. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review.

Objective

To summarize and critically appraise the available evidence on exercise therapy and other types of physical therapies for patients with neuromuscular diseases (NMD).

Data Sources

Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews, Medline, CINAHL, EMBASE (Rehabilitation and Physical Medicine), and reference lists of reviews and articles.

Study Selection

Randomized clinical trials (RCTs), controlled clinical trials (CCTs), and other designs were included. Study participants had to have any of the following types of NMD: motoneuron diseases, disorders of the motor nerve roots or peripheral nerves, neuromuscular transmission disorders, or muscle diseases. All types of exercise therapy and other physical therapy modalities were included. Outcome measures had to be at the level of body functions, activities, or participation according to the definitions of the International Classification of Functioning, Disability and Health (ICF).

Data Extraction

Two reviewers independently decided on inclusion or exclusion of articles and rated the methodologic quality of the studies included. All RCTs, CCTs, and other designs only if of sufficient methodologic quality were included in a best evidence synthesis. A level of evidence was attributed for each subgroup of NMD and each type of intervention.

Data Synthesis

Initially 58 studies were included: 12 RCTs, 5 CCTs, and 41 other designs. After methodologic assessment, 19 other designs were excluded from further analysis. There is level II evidence (“likely to be effective”) for strengthening exercises in combination with aerobic exercises for patients with muscle disorders. Level III evidence (“indications of effectiveness”) was found for aerobic exercises in patients with muscle disorders and for the combination of muscle strengthening and aerobic exercises in a heterogeneous group of muscle disorders. Finally, there is level III evidence for breathing exercises for patients with myasthenia gravis and for patients with myotonic muscular dystrophy. Adverse effects of exercise therapy were negligible.

Conclusions

The available evidence is limited, but relevant for clinicians. Future studies should be preferably multicentered, and use an international classification of the variables of exercise therapy and an ICF core set for NMD in order to improve comparability of results.

Key Words: Exercise therapy, Neuromuscular diseases, Physical therapy modalities, Rehabilitation, Review literature

 

NEUROMUSCULAR DISEASES (NMD) represent a heterogeneous group of disorders, including motoneuron diseases, disorders of motor nerve roots or peripheral nerves, neuromuscular transmission disorders, and muscle diseases.1, 2 The progression of the diseases varies considerably. The deficits can range from muscle weakness, sensory loss, pain, fatigue, and autonomic dysfunction in varying combinations. These deficits combine to lead to impairments of musculoskeletal and sensory functions, limitations in activities, and restrictions in participation.2

There are approximately 600 different NMDs with great variety in referral to physical therapy (PT).3 There is no consensus regarding the type and intensity of PT.4 PT often includes exercise therapy to improve or preserve muscle function (strength, endurance) and aerobic capacity to prevent or reduce secondary problems such as contractures, pain, or fatigue.2, 4 The benefits or injurious effects of exercises in NMD are unclear, and this uncertainty is particularly pertinent when the consideration of the “appropriate” level of intensity is addressed.5, 6, 7, 8, 9, 10, 11

Three Cochrane systematic reviews thus far focused on 1 type of NMD or a specific type of exercise therapy and were restricted to randomized clinical trials (RCTs) or controlled clinical trials (CCTs). In their Cochrane review on muscle strength training and aerobic exercise training for patients with muscle diseases, van der Kooi et al12 concluded that moderate-intensity strength training in myotonic dystrophy and facioscapulohumeral muscular dystrophy appeared not to be harmful, but there was insufficient evidence to establish its benefit. This conclusion was based on 2 RCTs.13, 14 White et al15 did a Cochrane review on exercise therapy for people with peripheral neuropathy and concluded that there is insufficient evidence to evaluate the effect of exercise therapy on functional ability in people with this condition. This was based on 1 RCT,13 which was also included in the review by van der Kooi.12 Ashworth et al,16 reviewing treatment for spasticity in patients with amyotrophic lateral sclerosis (ALS), concluded that the available evidence was insufficient to determine whether individualized exercises for muscle endurance of the trunk and limbs with moderate intensity are beneficial or harmful for these patients. The conclusion was also based on 1 single RCT performed.17

When RCTs are scarce, evidence from nonrandomized studies and other designs, such as pre-post studies or case-control studies, may be particularly relevant.18 There are previous reviews on exercise therapy for patients with NMD,9, 10 including other designs. However, these reviews lack a systematic approach.

Our aim here is to summarize and critically appraise the available evidence on exercise therapy and other modalities of physical therapies for patients with NMD to support neurologists, physicians, and physical therapists in their clinical decision-making for the individual patient with NMD. We conducted a comprehensive systematic review, including RCTs, CCTs, and other designs, all types of exercise and PT and all types of NMD.

Back to Article Outline

Methods 

Search Strategy 

We searched in the Cochrane Central Register of Controlled Trials (Cochrane Library 2005, Issue 3), Ovid Medline In-Process & Other Non-Indexed Citations and Ovid Medline (1966 through September 2005), CINAHL WebSPIRS 5.1 (1982 through September 2005), and EMBASE WebSPIRS 5.03 (Rehabilitation and Physical Medicine) (1995 through September 2005). We also searched in the Cochrane Database of Systematic Reviews to find articles indirectly by screening reference lists. Further, potentially relevant publications were searched manually through citation and author tracking.

Our broad search strategy was built on the following components: (1) RCTs and CCTs as recommended by the Cochrane Neuromuscular Disease Group; (2) other designs, such as pre-post designs; (3) types of NMD; and (4) PT modalities. For all search strategies Medical Subject Headings (MeSH) or indexed terms were used as well as free-text words. The full search strategy is available on request from the corresponding author.

Selection Criteria 

Inclusion was restricted to articles with an abstract, and language had to be English, German, French, or Dutch. The following study designs were included: RCTs, CCTs, and other designs such as pre-post studies. Case studies were excluded.

Participants included adults having one of the following types of NMD: (1) motoneuron diseases; (2) motor nerve root and peripheral nerve disorders; (3) neuromuscular transmission disorders; or (4) muscle disorders. Excluded were children or adolescents (<18y) with Duchenne’s muscular dystrophy, spinal muscular atrophy, or Becker’s muscular dystrophy. Also, patients having signs and symptoms of muscle weakness, pain, or fatigue not related to specific NMD were excluded, as well as diagnoses including chronic fatigue syndrome, spinal cord injuries, thoracic outlet syndrome, reflex sympathetic dystrophy or complex regional pain syndrome, cancer, or acquired immune deficiency syndrome. Although often classified as NMD, diabetic neuropathies, and entrapment neuropathies such as carpal tunnel syndrome and radiculopathies were not included in this review.

Regarding the type of interventions, we included different modalities of PT: (1) muscle strengthening exercises; (2) aerobic exercises; (3) breathing exercises; (4) other interventions such as relaxation techniques, exercises to improve mobility including transfers and walking, functional electric stimulation, education of the patient, family and caregivers; or (5) a combination of these interventions. Comprehensive rehabilitation programs were excluded, because it is impossible to isolate the effectiveness of PT in such programs.

Outcome measures had to be at the level of body functions, activities, or participation according to the definitions of the International Classification of Functioning, Disability and Health (ICF).19 Outcome measures at the level of body functions included measures for muscle strength or muscle endurance, range of motion, aerobic capacity, pulmonary function, respiration, pain, or fatigue. Excluded were measures for blood pressure as well as blood parameters, such as lactate. Outcome measures at the level of activities and participation included indices for walking and moving around, self-care, work and employment, domestic life, leisure, quality of life, or general health.

Procedure for Inclusion 

In all databases a preliminary selection, based on title and abstract, was carried out by 2 reviewers (EHC, AJP) independently. Studies that seemed to fit inclusion criteria were retrieved for more detailed evaluation (fig 1). In case of doubt, the reviewers collaboratively decided on retrieval of the full article.

Another pair of reviewers (EHC, JMB-P) independently decided on the inclusion or exclusion based on detailed information in the full articles. If disagreements persisted, a third reviewer (AJP) was consulted. The 2 reviewers (EHC, JMB-P) also independently scanned the reference lists of all articles and reviews for additional articles. Additional articles fulfilling the inclusion criteria, as well as relevant related articles and reviews found during the process of hand searching were retrieved for more detailed evaluation. Final inclusion or exclusion of the articles was always based on independent assessments of 2 reviewers (EHC, JMB-P).

Methodologic Quality 

The methodologic quality of the RCTs, CCTs, and other designs was rated using the list recommended by van Tulder et al.20 The quality of the internal validity was scored with 11 criteria (random assignment, allocation concealed, care provider blinded, cointerventions standardized, compliance ≥70%, patient blinded, outcome assessor blinded, outcome measures relevant, drop-out rate acceptable, timing of outcome assessment comparable, intention-to-treat analysis). Descriptive quality was scored with 8 criteria (eligibility criteria, similarity of groups at baseline, interventions, adverse effects, short-term follow-up, long-term follow-up, sample size, point estimates, measures of variability). All criteria were scored as yes, no, or unclear. Equal weight was given to all items. For the other designs, only the criteria that were applicable (7 criteria for internal validity and 7 criteria for descriptive quality) were used.

RCTs and CCTs were considered to be of sufficient quality if at least 6 of 11 criteria for internal validity and 4 of 8 descriptive criteria were scored positively. The other designs were considered to be of sufficient quality if at least 4 of 7 criteria for internal validity and 4 of 7 descriptive criteria were scored positively. Two reviewers (EHC, JMB-P) independently rated the methodologic quality of the trials. Disagreements were resolved by discussion.

We decided to exclude other designs of insufficient methodologic quality from further analysis because of their lack of value for the best evidence synthesis.

Classification of Included Studies 

The studies were classified based on type of NMD and type of intervention. For each study, the design, the methodologic quality, the number of participants, the diagnosis, the exercise intensity, frequency and duration, and outcome was presented (table 1).

Table 1. Classification of PT Studies in Type of NMD
StudyDesignVDNDiagnosisType of Intervention (type of exercises, type of muscles, load, number of repetitions, sets, progression)Frequency and DurationBody FunctionsActivities/Participation
1. Motoneuron disorders
Muscle strengthening exercises
Drory et al17RCT†3725ALSAROM exercises for muscles of limbs and trunk against modest loadsTwice a day 15min for 12mo1/8†1/4†
Klein et al50RCT⁎4429PPS3−5 AROM exercises for hip and knee extensors against gravity. RPE 12−14, increasing number of repetitionsDaily 30min for 16wk2/5⁎NV
Prins et al55RCT†4516PPSAquatic exercise: swimming and exercises for arms and legs using fins and paddles3×/wk 45−70min for 8wk7/39†NV
Chan et al48RCT⁎3710PPS3 sets of eight 3−5s 50% MVC of thenar muscle. If possible increase of 10% a week until 70% MVC level3×/wk for 12wk2/2⁎∥NV
Fillyaw et al59OD‡4517PPSFull AROM exercises for knee or elbow: 3 sets of 10 repetitions with weights. 1st set weight of 50% of 10-RM; 2nd set 75% and 3rd set 100% of 10-RM. 10-RM weight was evaluated every 2 weeksEvery other day up to 2y2/3∥NV
Einarsson58OD§4712PPS12 sets of 8 maximal isokinetic knee extensors contractions at 180°/s angular speed interposed with 12 sets of isolated 4-s isometric contractions3×/wk (96s) for 6wk5/7∥NV
Agre et al56OD5612PPS6 repetitions (30s each) of knee extension with weight of 1−1.5kg until RPE 17 or until 10 reps. If RPE <17 weight was increased (.23 kg)Every other day up to 12wk0/5NV
Agre et al57OD567PPSTuesday and Friday: 3 sets of 12 reps with ankle weights (1–1.5 kg). If RPE <19, the weight increased (.23kg) the next session. Monday and Thursday: 3 sets of 4 max effort isometric quadriceps contractions (5s)4d/wk for 12wk6/6∥NV
Aerobic exercises
Jones et al60RCT†5737PPSCycle ergometer at intensity of 70%−75% of HRR plus resting HR. Bouts of 2−5min, 1-min rest3×/wk 15−30min for 16wk4/7†∥NV
Dean and Ross53CCT⁎†4620PPSTreadmill walking at comfortable speed, RPE ≤5 (somewhat heavy)3×/wk 20−40min for 6wk
0/1†

2/7⁎

1/2⁎
Muscle strengthening and aerobic exercises
Willen et al61CCT†4528PPSFitness in water: resistance and endurance activities, balance, stretching and relaxation, avoiding muscle fatigue2×/wk 40min for 8mo3/20†0/4†
Lifestyle modification
Klein et al50RCT⁎4429PPSLifestyle modification to avoid shoulder overuseMonthly for 16wk1/5⁎NV
Muscle strengthening exercise and lifestyle modification
Klein et al50RCT⁎4429PPS3−5 AROM exercises for hip and knee extensors against gravity, increasing number of repetitions. RPE 12−14Daily 30min for 16wk0/5⁎NV
2. Motor nerve root disorders and peripheral nerve disorders
Muscle strengthening exercises
Lindeman et al13, 25RCT†6729HMSNExercises of muscles of hip and knee. Weeks 1−8: 3 sets of 25 repetitions of 60% of 1-RM; weeks 9−16: 3 sets of 15 repetitions of 70% of 1-RM; from week 18: 10 repetitions of 80% of 1-RM3×/wk 30min for 24wk1/4†1/6†
Chetlin et al23, 24OD5620HMSN3 sets of varying repetitions for flexion and extension at 40% to 50% MVIS for knee and 20% to 30% MVIS for elbow. Every 4 weeks, resistance increased. Reps increased weekly from 4 to 6 to 8 to 10Daily for 12wk3/94/4∥
Muscle strengthening and aerobic exercises
Ruhland and Shields51RCT⁎4528CPNExercises with Theraband with no resistance and progressing to light and medium resistance with 10 repetitions. Aerobic conditioning at 60%−70% of estimated maximal HR or “somewhat hard” on Borg RPE ScaleDaily 20min for 6wk2/4⁎1/11⁎
3. Neuromuscular transmission disorders
Breathing exercises
Fregonezi et al26RCT†⁎6627MGTen minutes of diaphragmatic breathing, followed by 10-min interval-based inspiratory muscle training and 10min of pursed lips breathing. Initial load 20% of Pimax, increased to 30% in week 3, 45% in the fifth week, and 60% in week 7.3×/wk 45min for 8wk
4/19†

10/19⁎∥


1/9†

1/9⁎

4. Muscle disorders
Muscle strengthening exercises
Van der Kooi et al14RCT†7765FSHDDynamic and isometric exercises for elbow flexors and ankle dorsiflexors, weeks 1−8: 2 sets of 5−10 repetitions with 10-RM weights, interspersed with 30s isometric exercise with 10-RM; weeks 9−17: sets of 8 reps with 8-RM weights; from week 18: 5 reps of 5-RM.3×/wk for 52wk2/12†0/3†
Lindeman et al13, 25RCT†6733MMDExercises of muscles of hip and knee. Weeks 1−8: 3 sets of 25 reps of 60% of 1-RM; weeks 9−16: 3 sets of 15 reps of 70% of 1-RM; from week 18: 10 reps of 80% of 1-RM3×/wk 30min for 24wk0/4†0/6†
Belanger and Noel52CCT⁎466
MMD(5)

LGD(1)

Maximal contractions of dorsiflexors and plantarflexors with ankle exerciser. Two sets of 10 MVC of 3−5s for dorsiflexors and for plantarflexorsDaily for 4mo0/2⁎0/4⁎
Alexanderson et al63OD6611
PM(7)

DM(4)

Warming up. Exercises for shoulder mobility and grip strength with a pulley apparatus, exercises for quadriceps and hip muscles, sit ups, and stretching. If FI score >38 exercises with weights (.25−2.0kg) were included. Also 15-min walking at self-selected speed5×/wk 15min for 12wk4/5∥3/8
Arnadottir et al64OD657sIBMExercises for shoulder mobility with a pulley apparatus, resistive exercises for shoulder and hip muscles, quadriceps and neck and trunk muscles. (10 reps of each exercise); weight cuffs (.25−2.0kg) depending on FI score (>38) and self-paced walking (15min)5×/wk for 12wk0/3NV
Aldehag et al62OD665MMD 1Hand exercises with silicone-based putty with isolated (1-2-3 sets of 3 reps or 1-2-3 sets of 5 reps) and mass (1-2-3 sets of 10 reps or 1-2-3 sets of 15 reps) movements, starting with 1 set of 3–5 reps in isolated movements and 1 set of 10−15 reps in mass movements. Number of sets increased every 4 weeks. Stretching was also included3×/wk 4min for 12wk7/12∥3/4∥
Sandin and Jonsson65OD5512WMHand exercises with silicone-based putty with isolated (1-2-3 sets of 3 reps or 1-2-3 sets of 5 reps) and mass (1-2-3 sets of 10 reps or 1-2-3 sets of 15 reps) movements, starting with 1 set of 3–5 reps in isolated movements and 1 set of 10−15 reps in mass movements. Number of sets increased every 4 weeks. Stretching was also included3×/wk 45min for 12wk4/141/2
Tollbäck et al66OD‡469MMDMaximal AROM exercises for knee extensors with weights on an iron shoe with increasing load. Week 1: 60% of 1-RM; week 2: 70% of 1-RM; thereafter 80% of 1-RM. 3 sets of 8 reps were performed3×/wk for 12wk1/4NV
Aerobic exercises
Taivassalo et al70OD§4524
MM(14)

NMM(10)

Treadmill exercise 70% to 85% of HRR3−4×/wk 20−30min for 8wk2/2∥1/1∥
Taivassalo et al69OD5510MM
Treadmill exercise at 60%−80% of HRR

Exercise until reaching the RPE of 15 (“hard”)

3−4×/wk 20−30min for 8wk4/4∥1/1∥
Taivassalo et al71OD5510MMCycling at 70%−80% of maximal HR3−4×/wk 30−40min for 14wk4/6∥NV
Trenell et al72OD§5510MMCycling at 70%−80% of maximal HR3×/wk 30min for 12wk2/3∥1/1∥
Haller et al67OD458MDCycling at 60%−70% of maximal HR4×/wk 30−40min for 14wk3/3∥NV
Olsen et al68OD558FSHDCycling at 65% of V̇o2max5×/wk 35min for 12wk2/2∥NV
Sunnerhagen et al73OD558HM
Cycling at 70% of maximal workload

Subjective workload with a target of 5 (Borg category scale with exponential increments from 0−10)

5×/wk 30min for 8wk1/31/4
Muscle strengthening and aerobic exercises
Cejudo et al49RCT⁎4720MMCycling 30min at 70% of peak work rate; and 3 dynamic isotonic arm weight (50% 1-RM, repeated every 2wk) lifting procedures through full ROM; shoulder press (shoulder, upper back, arm muscles), butterfly (pectoralis major) and biceps curls (biceps brachii, brachialis). Week 1 and 2: 1 set of 10−15 reps; next weeks: 2−3 sets3×/wk 60min for 12wk13/18⁎∥2/4⁎
Wiesinger et al27RCT†6714DM/PM
Cycling: 3−5min warming up; resistance increased until 60% of maximal HR. Step aerobics 30min at different rate levels adjusting load of exercises. Last 5min cooling down and stretching exercises

First 2 weeks, 2×/wk; remaining 4 weeks, 3×/wk

2−3×/wk 60min for 6wk2/2†∥1/1†∥
Wiesinger et al54CCT⁎578DM/PM
Cycling: 3−5min warm-up; resistance increased until 60% of maximal HR. Step aerobics 30min at different rate levels adjusting load of exercises. Last 5min, cooling down and stretching exercises

First 2wk, 2×/wk; 4wk, 3×/wk; remaining 18wk, 1×/wk

1−3×/wk 60min for 6mo6/8⁎∥1/1⁎∥
Muscle strengthening exercises, respiratory exercises and mud/massage/bath
Varju et al74OD4521DM/PM
Assisted bending and stretching of all joints; isotonic muscle training until fatigue. Movements were repeated until 65%−70% of max reps, then rest for 3min. If muscles were too weak, a sling was used.

Breathing exercises included instructions how to put hands on abdomen and rib cage and feeling and controlling movements, mud/massage/bath

5×/wk 40−60min for 3wk9/182/4
Breathing exercises
Ugalde et al75OD§4511MMDPursed lips breathing as voluntary expiratory blowing through partially closed lips to create a resistance at the mouth compared to matched volume breathing (exhaling without pursing lips) and tidal breathing (comfortable breathing without pursing lips)120s of each breathing condition6/9∥NV
5. Heterogeneous neuromuscular disorders
Strengthening exercises
Aitkens et al76OD‡§4427MMD(n=12) HMSN(n=8) LGD(n=3) SMA(n=2) FSHD(n=2)Initially 3 sets of 4 reps with speed of 30/s for knee extensor with ankle weights of 30% of max isometric knee extension force; and also for elbow flexors with weight of 10% of max elbow flexion force. Also 3 sets of 4 reps for hand grip exercises. Increasing resistance and reps3×/wk 15−20min for 12wk7/11∥NV
Kilmer et al77OD‡§6510MMD(n=5) LGD(n=3) HMSN(n=2)Knee extensors and elbow flexors with ankle and wrist cuff weights, 1 set of 10 reps with 12-RM, gradually increasing until 5 sets of 10 reps during 4d/wk. After week 5, resistance was increased by .45kg/wk (1lb/wk) if feasible. After week 9, from 4 to 5 sets3−4×/wk for 12wk3/10NV
Aerobic exercises
Florence and Hagberg28CCT⁎6512CCD (n=1) NM (n=1) MyM (n=1) SMA (n=1) CMD (n=2) LGD (n=3) CMT (n=2) FSHD (n=1)Cycling on cycle ergometer 5-min exercise bouts, 2-min rest at 70% of V̇o2max: resistance was adjusted to continually elicit 70% of V̇o2max3×/wk for 12wk3/5⁎∥0/2⁎
Wright et al78OD4511MMD (n=7); HMSN (n=3) LGD (n=1)
Walking with training at HR of 50%−60% HRR

Weeks 1 and 2: 3×/wk 15min; week 3: 20−30min; week 5–9 options to increase frequency to 4×/wk

3−4×/wk 15−20−30min 12wk1/33NV
Muscle strengthening and aerobic exercises
Dawes et al21RCT†⁎7618Becker MD (n=4) MMD (n=4) PM (n=1) FSHD (n=3) IMB (n=1) LGD (n=4) CM (n=1)Walking for as long as possible at light subjective exercise intensity up to 20min, then increase toward a moderate intensity (Borg CR-10 scale). Two exercises for each leg muscle endurance and core stability increasing the number of repetitions and range until 2.5min for each exercise. Then increasing difficulty with gravity as resistance, increasing number of repetitionsAlternate days for 8wk
1/7†



0/6†

0/6⁎

Abbreviations: Activities/participation, number of variables at the level of activities or participation with significant change divided by total number of variables at the level of activities or participation; AROM, active range of motion; Becker MD, Becker muscular dystrophy; Body functions, number of variables at the level of body functions with a significant change divided by the total number of variables at the level of body functions; Borg CR-10 scale, exercise symptom rating scale; CCD, central core disease; CM, congenital myopathy; CMD, congenital muscular dystrophy; CMT, Charcot-Marie-Tooth; CPN, chronic peripheral neuropathy; D, descriptive criteria (maximum, 8); DM, dermatomyositis; FI, functional index in myositis; FSHD, facioscapulohumeral muscular dystrophy; HM, hereditary myopathy; HMSN, hereditary motor and sensory neuropathy; HR, heart rate; HRR, heart rate reserve; IBM, inclusion body myositis; LGD, limb girdle dystrophy; MD, McArdle’s disease; MG, myasthenia gravis; MM, mitochondrial myopathy; MMD, myotonic muscular dystrophy; MVC, maximum voluntary contraction; MVIS, maximal voluntary isometric strength; MyM, myotubular myopathy; N, number of patients included in the study; NM, nemaline myopathy; NMM, nonmetabolic myopathy; NV, no variables in this area; OD, other design; PM, polymyositis; PPS, postpoliomyelitis syndrome; reps, repetitions; RPE, rating of perceived exertion; sIBM, sporadic inclusion body myositis; SMA, spinal muscular atrophy; V, criteria for internal validity (maximum, 11); V̇o2max, maximum oxygen uptake; WM, Welander myopathy; xRM, repeated maximum (maximum weight, which can be lifted x repetitions).

⁎Analysis within groups;

†analysis between groups.

‡One side of the body randomly chosen for exercise, contralateral side of the body served as control.

§Comparison with a reference group of healthy subjects.

∥Results significant (P<.05) for more than half of the variables.

Studies comparing a group of patients with a reference group of healthy persons were categorized as other designs. Also studies in which 1 side of the body was exercised and the contralateral side of the body served as control were treated as other designs.

The type of intervention was categorized into the different modalities of PT: (1) muscle strengthening exercises; (2) aerobic exercises; (3) breathing exercises; (4) other interventions; or (5) a combination of these modalities. For the different types of exercise therapy, the intensity was described, if the article provided enough details.

We divided the outcome variables into 2 categories: 1 category with outcome variables at the level of body functions and a second category including outcome variables at the level of activities and participation. This is based on the corresponding components in the ICF.19 Adverse effects were presented separately. The aim was to present primary and secondary outcomes for each study. However, only few studies defined primary and secondary outcome measures.14, 21 We then decided to include all outcome variables fulfilling the inclusion criteria and considered them of equal importance. Within each category (body functions or activities/participation, respectively), the number of variables that showed a statistically significant (P<.05) effect in a study was divided by the total number of outcome variables in the study. If presented in the article, different subscales of an instrument were treated as different outcome variables. A study was considered to provide evidence of effectiveness if more than half of the variables showed a significant effect.

Best Evidence Synthesis 

The comprehensive scope of our review and the heterogeneity in patient populations, interventions, and outcome measures precludes quantitative analysis (meta-analysis) of the data. We used a best evidence synthesis based on a classification of the Dutch Institute for Healthcare Improvement.22 The following levels of evidence were attributed based on the hierarchy of evidence. Recommendations were formulated accordingly.

Level I evidence is based on (a systematic review of) at least 2 independent RCTs of sufficient methodologic quality and leads to the conclusion: “It has been shown that.…” Level II evidence is based on 1 good quality RCT or at least 2 independent controlled studies (RCTs or CCTs) of less methodologic quality and leads to the conclusion: “It is likely that.…” Level III evidence is based on an RCT or CCT of low methodologic quality or at least 1 other design of sufficient methodologic quality. The conclusion is formulated as “There are indications that.…” In case of inconsistent findings in studies of similar design and methodologic quality (studies with and without evidence), the conclusion is formulated as “There is insufficient evidence that.…” If studies showed consistent significant findings, a level of evidence was attributed for each subgroup of NMD and each type of intervention.

Back to Article Outline

Results 

Selection of Studies 

The search resulted in 5712 citations (see fig 1). Of these, 5634 articles were excluded because the type of study, the participants, the intervention, or outcome measures did not meet the predefined criteria.

The preliminary selection resulted in 62 articles and 16 reviews that were retrieved for more detailed evaluation. Citation tracking resulted in 19 additional reviews and 27 additional articles to be retrieved. The final selection resulted in a total of 60 articles, comprising 58 different studies, because 2 studies were published twice.13, 23, 24, 25 Among these studies were 12 RCTs, 5 CCTs, and 41 other designs.

Methodologic Quality 

Five of 12 RCTs13, 14, 21, 26, 27 and 1 of 5 CCTs28 had sufficient methodologic quality (a score of ≥6/11 for internal validity and ≥4/8 for descriptive quality). Of the other designs, 22 studies had sufficient methodologic quality (a score of ≥4/7 for internal validity and ≥4/7 for descriptive quality). Nineteen other designs had insufficient methodologic quality and were excluded from further analysis.29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47

Two RCTs17, 48 had a lower score on the validity criteria than we accepted from other designs.

Four RCTs48, 49, 50, 51 and 4 CCTs28, 52, 53, 54 presented only within-group analysis, but no between-groups comparisons. These studies were treated as other designs in the best evidence synthesis.

The methodologic quality of all studies included in the best evidence synthesis is presented in table 1.

Best Evidence Synthesis 

The best evidence synthesis is based on the information presented in table 1. For each subgroup of NMD and each type of intervention, the evidence is summarized.

Motoneuron Disorders 

Muscle strengthening exercises 

Four RCTs17, 48, 50, 55 and 4 other designs56, 57, 58, 59 studied muscle strengthening exercises in NMD. None of the RCTs had sufficient methodologic quality. One RCT17 included patients with ALS and all other studies included patients with postpoliomyelitis syndrome (PPS).

The low quality RCT17 on muscle strengthening exercises in patients with ALS reported significant findings in 1 of 8 variables on body functions and 1 of 4 variables on activities and participation. According to the criteria used in this review, this implies that there is insufficient evidence for the effectiveness of muscle strengthening exercises for patients with ALS.

Three RCTs48, 50, 55 of insufficient methodologic quality and 4 other designs56, 57, 58, 59 studied muscle strengthening exercises in PPS. The type and intensity of strengthening exercises and the outcome variables differed in all studies. Although 4 studies (1 RCT, 3 other designs) showed significant effects in most outcome variables at the level of body functions, the other 3 studies (2 RCTs, 1 other design) resulted in insufficient evidence of effectiveness. Hence, according to our criteria, there is insufficient evidence for the effectiveness of muscle strengthening exercises for patients with PPS.

Aerobic exercises 

One RCT60 and 1 CCT,53 both of limited methodologic quality, studied the effectiveness of aerobic exercise in PPS. The RCT showed a significant effect in 4 of 7 outcome variables in the category body functions. The CCT showed no significant results in the between-groups analysis. In the within-group analysis, significant results were found for 2 of 7 variables on body functions and in 1 of 2 variables on activities and participation level. Our conclusion is that there is insufficient evidence for the effectiveness of aerobic exercises for patients with PPS.

A combination of muscle strengthening and aerobic exercises 

One CCT61 of insufficient methodologic quality evaluated the combination of muscle strengthening exercises and aerobic exercises in patients with PPS. Three of 20 variables on body functions and none of the outcome variables on activities and participation showed a significant effect. Hence, there is insufficient evidence for the effectiveness of a combination of muscle strengthening exercises and aerobic exercises for patients with PPS.

Lifestyle modification with or without muscle strengthening exercises 

One study with a randomized parallel group design evaluated the effectiveness of lifestyle modification alone and in combination with muscle strengthening exercise in PPS.50 The methodologic quality of the study was insufficient. There was a significant effect in 1 of 5 variables on body functions in the group receiving the lifestyle modification. The group combining the 2 intervention strategies showed no significant findings. In conclusion, there is insufficient evidence for the effectiveness of lifestyle modification techniques, with or without muscle strengthening exercises for patients with PPS.

Motor Nerve Root Disorders and Peripheral Nerve Disorders 

Muscle strengthening exercises 

One RCT13 of sufficient methodologic quality studied the effect of muscle strengthening exercises for patients with hereditary motor and sensory neuropathy (HMSN). Significant findings were found in 1 of 4 variables on body functions and 1 of 6 variables on activities and participation.13, 25 One other design23, 24 showed significant findings in 3 of 9 variables on body function and all 4 variables on activities and participation. Based on these findings, the conclusion is that there is insufficient evidence for the effectiveness of muscle strengthening exercises in patients with HMSN.

A combination of muscle strengthening and aerobic exercises 

One RCT51 of insufficient methodologic quality studied the effectiveness of muscle strengthening and aerobic exercises in chronic peripheral neuropathy (CPN). There were significant findings in 2 of 4 variables on body functions and in 1 of 11 variables on activities and participation. Our conclusion is that there is insufficient evidence for the effectiveness of strengthening exercises in combination with aerobic exercises in patients with CPN.

Neuromuscular Transmission Disorders 

Breathing exercises 

One RCT with sufficient methodologic quality studied the effectiveness of inspiratory muscle training and diaphragmatic breathing and pursed lips breathing in patients with myasthenia gravis (MG).26 Four of 19 variables on body functions and 1 of 9 variables on activities and participation showed a significant effect in the analysis between groups. The within-group analysis showed a significant effect in 10 of 19 variables on body function. If we consider this study as another design, then the conclusion is that there are indications for the effectiveness of breathing exercises in patients with MG (level III evidence).

Muscle Disorders 

Muscle strengthening exercises 

Two RCTs13, 14, 25 of sufficient methodologic quality, 1 CCT52 with insufficient methodologic quality and 5 other designs62, 63, 64, 65, 66 studied strengthening exercises for patients with muscle disorders. Different types of muscle disorders and different muscle groups were studied. There was also much variety in type and intensity of strengthening exercises and in the outcome variables. The RCTs and CCTs showed hardly significant findings, either at the level of body functions or at the level of activities and participation. The findings of the other designs were inconsistent. In conclusion, there is insufficient evidence for the effectiveness of muscle strengthening exercises for patients with muscle disorders.

Aerobic exercises 

Seven other designs67, 68, 69, 70, 71, 72, 73 studied aerobic exercises for patients with muscle disorders. Six other designs67, 68, 69, 70, 71, 72 showed consistent significant findings at the level of body functions and at the level of activities and participation. One other design73 showed significant findings in only 1 of 3 outcome variables on body function. The outcome variable that showed a significant effect was a measure of aerobic capacity; the other 2 were strength measures. In conclusion, there are indications that aerobic exercises have a positive effect on body functions as well as activities and participation in patients with muscle disorders (level III evidence).

A combination of muscle strengthening and aerobic exercises 

Two RCTs27, 49 and 1 CCT54 studied the combination of muscle strengthening exercises and aerobic exercises in patients with muscle disorders. One RCT27 had sufficient methodologic quality, whereas the methodologic quality of the other RCT49 and the CCT54 was insufficient. The good quality RCT27 showed significant findings in all 2 variables at the level of body functions and in the only variable measured at the level of activities and participation. The low quality RCT49 and CCT54 showed significant findings consistent with the good quality RCT. In conclusion, it is likely that strengthening exercises in combination with aerobic exercises have a positive effect on body functions as well as on activities and participation in patients with muscle disorders (level II evidence).

A combination of muscle strengthening and breathing exercises and mud/massage/bath 

One other design74 showed significant findings in 9 of 18 variables at the level of body functions and 2 of 4 variables at the level of activities and participation. In conclusion, there is insufficient evidence for the effectiveness of the combination of strengthening and respiratory exercises and mud/massage/bath for patients with muscle disorders.

Breathing exercises 

One other design75 on pursed lips breathing in myotonic muscular dystrophy (MMD) showed significant findings on 6 of 9 variables on body functions. In conclusion: there are indications that pursed lips breathing is effective in patients with MMD (level III evidence).

Heterogeneous Group of Patients With NMD 

Muscle strengthening exercises 

Two other designs76, 77 studied muscle strengthening exercises in a heterogeneous group of patients with NMD. The findings were inconsistent. In conclusion, there is insufficient evidence for the effectiveness of muscle strengthening exercises for a heterogeneous group of NMD.

Aerobic exercises 

One CCT28 and other design78 studied aerobic exercises in a heterogeneous group of patients with NMD. The CCT was of sufficient methodologic quality and presented significant findings in 3 of 5 variables on body function.28 There were no significant findings at the level of activities and participation. Only within-group findings were presented, which means that we cannot consider this study to be a truly controlled trial. The other design78 showed a significant effect in only 1 of 33 variables on body functions. In conclusion, there is insufficient evidence for the effectiveness of aerobic exercises for a heterogeneous group of NMD.

Muscle strengthening and aerobic exercises 

One RCT21 of sufficient methodologic quality studied muscle strengthening and aerobic exercises in a heterogeneous group of NMD. The between-groups analysis showed a significant effect in 1 of 7 variables on body functions and none of the variables at the level of activities and participation. The within-group analysis showed a significant effect in 6 of 7 strength measures in the intervention group. If we consider this study as another design, then the best evidence synthesis leads to the conclusion that there are indications that a combination of muscle strengthening and aerobic exercises is effective in increasing muscle strength (level III evidence).

Adverse Effects 

Thirty-three studies reported absent or negligible adverse effects. Chetlin et al24 reported that 3 of 20 patients decreased their training for 1 or 2 sessions due to delayed-onset soreness. Six studies did not report whether exercise therapy resulted in adverse effects.

Other PT Modalities 

No studies were found on the application of functional electric stimulation or interventions to improve mobility including transfers and walking or education of the patient, family, and caregivers.

Back to Article Outline

Discussion 

Methodology 

The extensive search used in this review with MeSH terms exploded without restrictions and free-text words such as activities of daily living or physical activity, which resulted in a large database of citations. However, 90% of the citations did not fulfill our predefined inclusion criteria regarding the study design, the participants, the intervention, or the outcome measures. Surprisingly, hand searching of the reference lists of the articles and reviews revealed a substantial number of additional citations. Hopewell et al79 compared hand searches with Medline searching and found that 25% of reports of randomized trials with a Medline record were missed by the electronic search, because they did not have either of the publication type terms randomized controlled trial or controlled clinical trial. This was especially the case for reports of RCTs published prior to 1991. It shows the limitations of electronic searches and suggests the need to combine electronic searches and manual searches.18 Another explanation is that the indexing of other designs is less precise and reliable compared with RCTs.18

We included all RCTs and CCTs in our best evidence synthesis, regardless of their methodologic quality, and only the other designs of sufficient methodologic quality. Although RCTs are usually regarded as the highest level of evidence for judging the efficacy of therapeutic interventions, randomization should not be seen as a reliable proxy for overall quality.18 Well-conducted nonrandomized studies may be more valid than poorly conducted RCTs. In this review we found 2 RCTs17, 48 with a lower score on the criteria for internal validity than we accepted from other designs. Another unexpected finding was that 4 RCTs48, 49, 50, 51 and 4 CCTs28, 52, 53, 54 did not present between-groups comparisons. We recommend the presentation of between-group comparisons to be an additional criterion in the future rating of methodologic quality.

The various types of NMD and PT interventions in combination with the use of a variety of outcome measures required that decisions were made on classifications and cutoff points. We decided that more than half of the outcome variables in a given study had to show a significant effect in order to provide evidence. We presumed that all outcome variables were of similar importance, but this is arbitrary. It may have resulted in loss of evidence when effects of important variables were overruled by other variables without an effect. However, when we checked the actual variables, they were generally in agreement with our assumptions.

Finally, in our method, a study that provided evidence of effectiveness could be neutralized by studies without evidence. One can argue that this is too strict, considering the fact that a study could only provide evidence if more than half of the variables showed a significant effect. On the other hand, we were not strict in including all RCTs and CCTs, regardless of their methodologic quality and other designs of sufficient methodologic quality.

Exercise Intensity 

Most studies evaluated muscle strengthening exercises, aerobic exercises, or a combination of these. The intensity of strengthening exercises can be manipulated by varying the resistance or weight, the number of repetitions, the length of the rest interval, or the number of sets of exercises completed. The American College of Sports Medicine (ACSM) formulated minimal requirements to evaluate the quality of training programs for effective muscle strength training in healthy adults.80 The ACSM recommends a progressive individualized program, for all major muscle groups with at least 1 set of 8 to 12 repetitions and a frequency of 2 to 3 days a week. Obviously, these requirements for healthy persons cannot simply be applied to persons with NMD, because of lack of evidence regarding the effect of physical exertion on the diseased neuromuscular system. Overexerting muscles might accelerate disease progression.12 Still, the intervention should be of enough intensity to provide a training stimulus.

Nearly all studies on muscle strengthening exercises included in this review met the requirements of an individualized and progressive program. However, there was considerable variation in the muscles exercised, type of exercises given, and type of resistance, number of repetitions, and number of sets. Most investigators used a moderate level of intensity in order to prevent adverse effects. Indeed, a very important finding was the absence of adverse effects. If, however, the intensity is too low, one cannot expect an effect of training other than physiologic adaptations due to activation of muscles that might have been inactive before.

For aerobic exercises, ACSM recommends the use of large muscle groups in a rhythmic, aerobic, and continuous manner.18, 81 For most people, intensities within the range of 70% to 85% of maximum heart rate, or 60% to 80% of oxygen uptake reserve or heart rate reserve are sufficient to achieve improvements in cardiorespiratory fitness, when combined with an optimal frequency of 3 to 5 days a week.81 This review has shown that these intensities can be recommended for patients with NMD without adverse effects. Most of the included studies used cycling or treadmill exercise with a frequency of at least 3 times a week and exercise intensity around 70% of heart rate reserve or estimated maximum heart rate.

For both muscle strengthening and aerobic exercises the entire program should last at least 10 weeks and regular supervision optimizes the effect of training and improves safety and compliance.12 Yet, in only 30% of all studies on muscle strengthening and aerobic exercises, the duration of the interventions was less than 10 weeks, and in approximately 50% of the studies, the training was under regular supervision.

Uniformity 

To facilitate meaningful comparisons among studies and statistical power by effective pooling of study results, more uniformity is needed in type of interventions, intensity of exercise therapy, and type of outcome measures. To achieve more uniform terminology, we recommend the development of an international classification for PT modalities. In the Netherlands, such a classification has been developed for allied health care professionals.82 In this study, the ICF19 was used to make a distinction between outcome variables at the level of body functions and at the level of activities and participation. We recommend the development of ICF core sets specifically for NMD, like ICF core sets developed for other chronic diseases.83, 84, 85 This would provide professionals and researchers with a framework for the selection of assessment and outcome measures on body functions, activities and participation and on environmental factors for research as well as for clinical purposes.

Back to Article Outline

Conclusions 

Our best evidence synthesis resulted in level II evidence (likely to be effective) for strengthening exercises in combination with aerobic exercises for patients with muscle disorders. Level III evidence (indications of effectiveness) was found for aerobic exercises in patients with muscle disorders and for the combination of muscle strengthening and aerobic exercises in a heterogeneous group of patients with muscle disorders. Finally, there is level III evidence for breathing exercises for patients with MG and for patients with MMD. There was insufficient evidence for strengthening exercises due to insignificant or inconsistent effects. Most studies reported the absence of adverse effects.

Back to Article Outline

Acknowledgment 

We thank Sylvia van den Heuvel (Dutch Institute of Allied Health Care, Amersfoort, The Netherlands) for her assistance with the EMBASE search.

Back to Article Outline

References 

  1. de Visser M, Vermeulen M, Wokke JH. In: Neuromusculaire ziekten. Maarssen: Elsevier/Bunge; 1999;
  2. Dombovy ML. Rehabilitation management of neuropathies. In:  Dyck PJ,  Thomas PK editor. Peripheral neuropathy. 4th ed.. Philadelphia: Elsevier Saunders; 2005;p. 2621–2636
  3. Cup EH, Pieterse AJ, Knuijt S, et al. Referral of patients with neuromuscular disease to occupational therapy, physical therapy and speech therapy: usual practice versus multidisciplinary advice. Disabil Rehabil. 2007;29:717–726
  4. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases. Newcastle, January 2002. Neuromuscul Disord. 2002;12:975–983
  5. Alexanderson H, Lundberg IE. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2005;17:164–171
  6. Brinkmann JR, Ringel SP. Effectiveness of exercise in progressive neuromuscular disease. J Neuro Rehabil. 1991;5:195–199
  7. Kilmer DD. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11 Suppl):S121–S126
  8. Kilmer DD. Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11 Suppl):S148–S150
  9. Krivickas LS. Exercise in neuromuscular disease. J Clin Neuromuscul Dis. 2003;5:29–39
  10. Phillips BA, Mastaglia FL. Exercise therapy in patients with myopathy. Curr Opin Neurol. 2000;13:547–552
  11. Taivassalo T, Haller RG. Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc. 2005;37:2094–2101
  12. van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev. 2005;(1):CD003907
  13. Lindeman E, Leffers P, Spaans F, et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil. 1995;76:612–620
  14. van der Kooi EL, Vogels OJ, van Asseldonk RJ, et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology. 2004;63:702–708
  15. White CM, Pritchard J, Turner-Stokes L. Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev. 2004;CD003904
  16. Ashworth NL, Satkunam LE, Deforge D. Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2006;(1):CD004156
  17. Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:133–137
  18. Hartling L, McAlister FA, Rowe BH, Ezekowitz J, Friesen C, Klassen TP. Challenges in systematic reviews of therapeutic devices and procedures. Ann Intern Med. 2005;142:1100–1111
  19. World Health Organization. In: International classification of functioning, disability and health (ICF full version). Geneva: WHO; 2001;
  20. van Tulder MW, Assendelft WJ, Koes BW, Bouter LM. Method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group for Spinal Disorders. Spine. 1997;22:2323–2330
  21. Dawes H, Korpershoek N, Freebody J, et al. A pilot randomised controlled trial of a home-based exercise programme aimed at improving endurance and function in adults with neuromuscular disorders. J Neurol Neurosurg Psychiatry. 2006;77:959–962
  22. Kwaliteitsinstituut voor de Gezondheidszorg CBO. Evidence-based Richtlijnontwikkeling. Handleiding voor werkgroepleden. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO; 2005. Appendix A-1. Levels of Evidence.
  23. Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil. 2004;85:1217–1223
  24. Chetlin RD, Gutmann L, Tarnopolsky MA, Ullrich IH, Yeater RA. Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease. Muscle Nerve. 2004;30:69–76
  25. Lindeman E, Drukker J. Specificity of strength training in neuromuscular disorders. J Rehabil Sci. 1994;7:13–15
  26. Fregonezi GA, Resqueti VR, Guell R, Pradas J, Casan P. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest. 2005;128:1524–1530
  27. Wiesinger GF, Quittan M, Aringer M, et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol. 1998;37:196–200
  28. Florence JM, Hagberg JM. Effect of training on the exercise responses of neuromuscular disease patients. Med Sci Sports Exerc. 1984;16:460–465
  29. Alexanderson H, Stenstrom CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology. 1999;38:608–611
  30. Böhme P, Arnold CR. Limb-girdle muscular dystrophy—results of physical therapy under stationary conditions. Aktuel Neurol. 2004;31:1–5
  31. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Resp J. 2003;21:502–508
  32. DiMarco AF, Kelling JS, DiMarco MS, Jacobs I, Shields R, Altose MD. The effects of inspiratory resistive training on respiratory muscle function in patients with muscular dystrophy. Muscle Nerve. 1985;8:284–290
  33. Ernstoff B, Wetterqvist H, Kvist H, Grimby G. Endurance training effect on individuals with postpoliomyelitis. Arch Phys Med Rehabil. 1996;77:843–848
  34. Estrup C, Lyager S, Noeraa N, Olsen C. Effect of respiratory muscle training in patients with neuromuscular diseases and in normals. Respiration. 1986;50:36–43
  35. Feldman RM. The use of strengthening exercises in post-polio sequelae (Methods and results). Orthopedics. 1985;8:889–890
  36. Feldman RM, Soskolne CL. The use of nonfatiguing strengthening exercises in post-polio syndrome. Birth Defects Orig Artic Ser. 1987;23:335–341
  37. Garssen MP, Bussmann JB, Schmitz PI, et al. Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP. Neurology. 2004;63:2393–2395
  38. Klefbeck B, Lagerstrand L, Mattsson E. Inspiratory muscle training in patients with prior polio who use part-time assisted ventilation. Arch Phys Med Rehabil. 2000;81:1065–1071
  39. Lohi E, Lindberg C, Andersen O. Physical training effects in myasthenia gravis. Arch Phys Med Rehabil. 1993;74:1178–1180
  40. McCartney N, Moroz D, Garner SH, McComas AJ. The effects of strength training in patients with selected neuromuscular disorders. Med Sci Sports Exerc. 1988;20:362–368
  41. Milner-Brown HS, Miller RG. Muscle strengthening through high-resistance weight training in patients with neuromuscular disorders. Arch Phys Med Rehabil. 1988;69:14–19
  42. Milner Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil. 1988;69:20–24
  43. Orngreen MC, Olsen DB, Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol. 2005;57:754–757
  44. Siciliano G, Manca ML, Renna M, Prontera C, Mercuri A, Murri L. Effects of aerobic training on lactate and catecholaminergic exercise responses in mitochondrial myopathies. Neuromuscular Disord. 2000;10:40–45
  45. Spector SA, Gordon PL, Feuerstein IM, Sivakumar K, Hurley BF, Dalakas MC. Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy. Muscle Nerve. 1996;19:1282–1290
  46. Spector SA, Lemmer JT, Koffman BM, et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve. 1997;20:1242–1248
  47. Weiner P, Gross D, Meiner Z, et al. Respiratory muscle training in patients with moderate to severe myasthenia gravis. Can J Neurol Sci. 1998;25:236–241
  48. Chan KM, Amirjani N, Sumrain M, Clarke A, Strohschein FJ. Randomized controlled trial of strength training in post-polio patients. Muscle Nerve. 2003;27:332–338
  49. Cejudo P, Bautista J, Montemayor T, et al. Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve. 2005;32:342–350
  50. Klein MG, Whyte J, Esquenazi A, Keenan MA, Costello R. A comparison of the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study. Arch Phys Med Rehabil. 2002;83:708–713
  51. Ruhland JL, Shields RK. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther. 1997;77:1026–1039
  52. Belanger AY, Noel G. Compliance to and effects of a home strengthening exercise program for adult dystrophic patients: a pilot study. Physiother Can. 1991;43:24–30
  53. Dean E, Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics. 1991;14:1243–1246
  54. Wiesinger GF, Quittan M, Graninger M, et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol. 1998;37:1338–1342
  55. Prins JH, Hartung H, Merritt DJ, Blancq RJ, Goebert DA. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Training Rehabil. 1994;5:29–39
  56. Agre JC, Rodriquez AA, Franke TM, Swiggum ER, Harmon RL, Curt JT. Low-intensity, alternate-day exercise improves muscle performance without apparent adverse affect in postpolio patients. Am J Phys Med Rehabil. 1996;75:50–6278
  57. Agre JC, Rodriguez AA, Franke TM. Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Arch Phys Med Rehabil. 1997;78:681–686
  58. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil. 1991;72:11–14
  59. Fillyaw MJ, Badger GJ, Goodwin GD, Bradley WG, Fries TJ, Shukla A. The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome. Orthopedics. 1991;14:1253–1256
  60. Jones DR, Speier J, Canine K, Owen R, Stull GA. Cardiorespiratory responses to aerobic training by patients with postpoliomyelitis sequelae. JAMA. 1989;261:3255–3258
  61. Willen C, Sunnerhagen KS, Grimby G. Dynamic water exercise in individuals with late poliomyelitis. Arch Phys Med Rehabil. 2001;82:66–72
  62. Aldehag AS, Jonsson H, Ansved T. Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int. 2005;12:14–27
  63. Alexanderson H, Stenstrom CH, Jenner G, Lundberg I. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol. 2000;29:295–301
  64. Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med. 2003;35:31–35
  65. Sandin AA, Jonsson H. Evaluation of a hand-training programme for patients with Welander distal myopathy. Scand J Occup Ther. 2003;10:188–192
  66. Tollbäck A, Eriksson S, Wredenberg A, et al. Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med. 1999;31:9–16
  67. Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle’s disease. Ann Neurol. 2006;59:922–928
  68. Olsen DB, Orngreen MC, Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology. 2005;64:1064–1066
  69. Taivassalo T, De Stefano N, Argov Z, et al. Effects of aerobic training in patients with mitochondrial myopathies. Neurology. 1998;50:1055–1060
  70. Taivassalo T, De Stefano N, Chen J, Karpati G, Arnold DL, Argov Z. Short-term aerobic training response in chronic myopathies. Muscle Nerve. 1999;22:1239–1243
  71. Taivassalo T, Shoubridge EA, Chen J, et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol. 2001;50:133–141
  72. Trenell MI, Sue CM, Kemp GJ, Sachinwalla T, Thompson CH. Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle Nerve. 2006;33:524–531
  73. Sunnerhagen KS, Darin N, Tajsharghi H, Oldfors A. The effects of endurance training in persons with a hereditary myosin myopathy. Acta Neurol Scand. 2004;110:80–86
  74. Varju C, Petho E, Kutas R, Czirjak L. The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis. Clin Rehabil. 2003;17:83–87
  75. Ugalde V, Breslin EH, Walsh SA, Bonekat HW, Abresch RT, Carter GT. Pursed lips breathing improves ventilation in myotonic muscular dystrophy. Arch Phys Med Rehabil. 2000;81:472–478
  76. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993;74:711–715
  77. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1994;75:560–563
  78. Wright NC, Kilmer DD, McCrory MA, Aitkens SG, Holcomb BJ, Bernauer EM. Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program. Arch Phys Med Rehabil. 1996;77:64–69
  79. Hopewell S, Clarke M, Lusher A, Lefebvre C, Westby M. A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials. Stat Med. 2002;21:1625–1634
  80. American College of Sports Medicine. Position stand on the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30:975–991
  81. American College of Sports Medicine. General principles of exercise prescription. In:  Franklin BA,  Whaley MH,  Howley ET editor. ACSM’s guidelines for exercise testing and prescription. 6th ed.. Philadelphia: ACSM; 2000;p. 137–164
  82. Heerkens YF, Heuvel van J, Heuvel van den SP, Mischner-van Ravensberg CD. In: Ontwerpstandaard voor een Classificatie Verrichtingen Paramedische Bewegingsberoepen (CVPB). Amersfoort: SWSF; 1995;
  83. ICF Core Sets for stroke. J Rehabil Med. 2004;(44 Suppl):135–141
  84. ICF Core Sets for obstructive pulmonary diseases. J Rehabil Med. 2004;(44 Suppl):114–120
  85. ICF Core Sets for rheumatoid arthritis. J Rehabil Med. 2004;(44 Suppl):87–93
  86. Gross D, Meiner Z. The effect of ventilatory muscle training on respiratory function and capacity in ambulatory and bed-ridden patients with neuromuscular disease. Monaldi Arch Chest Dis. 1993;48:322–326
  87. Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, Haller RG. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126(Pt 2):413–423
  88. Horber FF, Scheidegger JR, Grunig BE, Frey FJ. Evidence that prednisone-induced myopathy is reversed by physical training. J Clin Endocrinol Metab. 1985;61:83–88
  89. Ahlstrom G, Lindvall B, Wenneberg S, Gunnarsson LG. A comprehensive rehabilitation programme tailored to the needs of adults with muscular dystrophy. Clin Rehabil. 2006;20:132–141
  90. Heim M, Yaacobi E, Azaria M. A pilot study to determine the efficiency of lightweight carbon fibre orthoses in the management of patients suffering from post-poliomyelitis syndrome. Clin Rehabil. 1997;11:302–305
  91. Janiszewski DW, Caroscio JT, Wisham LH. Amyotrophic lateral sclerosis: a comprehensive rehabilitation approach. Arch Phys Med Rehabil. 1983;6:304–307
  92. Milner Brown HS, Miller RG. Myotonic dystrophy: quantification of muscle weakness and myotonia and the effect of amitriptyline and exercise. Arch Phys Med Rehabil. 1990;71:983–987
  93. Sanjak M, Paulson D, Sufit R, et al. Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis. Neurology. 1987;37:1217–1220
  94. Waring WP, Maynard F, Grady W, Grady R, Boyles C. Influence of appropriate lower extremity orthotic management on ambulation, pain, and fatigue in a postpolio population. Arch Phys Med Rehabil. 1989;70:371–375
  95. Kelm J, Ahlhelm F, Regitz T, Pape D, Schmitt E. Controlled dynamic weight training in patients with neuromuscular disorders. [German] Fortschr Neurol Psychiatr. 2001;69:359–366
  96. Kriz JL, Jones DR, Speier JL, Canine JK, Owen RR, Serfass RC. Cardiorespiratory responses to upper extremity aerobic training by postpolio subjects. Arch Phys Med Rehabil. 1992;73:49–54
  97. Toedebusch B, LaFontaine T. Special populations (Strength and conditioning for persons with muscular dystrophy). Strength Cond J. 2005;27(3):39–41
  98. Agre JC, Rodriquez AA, Sperling KB. Symptoms and clinical impressions of patients seen in a postpolio clinic. Arch Phys Med Rehabil. 1989;70:367–370
  99. Dean E, Ross J. Modified aerobic walking program: effect on patients with postpolio syndrome symptoms. Arch Phys Med Rehabil. 1988;69:1033–1038
  100. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol. 1993;20:1340–1344
  101. Hicks JE. Rehabilitating patients with idiopathic inflammatory myopathy. J Musculoskeletal Med. 1995;12(4):41–4851
  102. Koessler W, Wanke T, Winkler G, et al. 2 years’ experience with inspiratory muscle training in patients with neuromuscular disorders. Chest. 2001;120:765–769
  103. Richardson JK, Thies SB, DeMott TK, Ashton-Miller JA. Interventions improve gait regularity in patients with peripheral neuropathy while walking on an irregular surface under low light. J Am Geriatr Soc. 2004;52:510–515
  104. Winkler G, Zifko U, Nader AF, et al. Dose-dependent effects of inspiratory muscle training in neuromuscular disorders. Muscle Nerve. 2000;23:1257–1260
  105. Zupan A, Gregoric M, Valencic V. Long-lasting effects of electrical stimulation upon muscles of patients suffering from progressive muscular dystrophy. Clin Rehabil. 1995;9:102–109
  106. Agre JC, Rodriquez AA. Intermittent isometric activity: its effect on muscle fatigue in postpolio subjects. Arch Phys Med Rehabil. 1991;72:971–975
  107. Ashton-Miller JA, Yeh MW, Richardson JK, Galloway T. A cane reduces loss of balance in patients with peripheral neuropathy: results from a challenging unipedal balance test. Arch Phys Med Rehabil. 1996;77:446–452
  108. Bakhtiary AH, Phoenix J, Edwards RH, Frostick SP. The effect of motor learning in facioscapulohumeral muscular dystrophy patients. Eur J Appl Physiol. 2000;83:551–558
  109. Heikkilä S, Viitanen JV, Kautiainen H, Rajamaki T, Mantyvuo P, Harju T. Rehabilitation in myositis: preliminary study. Physiotherapy. 2001;87:301–309
  110. Kilmer DD, Aitkens SG, Wright NC, McCrory MA. Response to high-intensity eccentric muscle contractions in persons with myopathic disease. Muscle Nerve. 2001;24:1181–1187
  111. Moon JH, Na YM, Kang SW, Lee HS. The changes in muscle strength and relaxation time after a comprehensive rehabilitation program for patients with myotonic dystrophy. Yonsei Med J. 1996;37:237–242
  112. Nitz J, Burke B. A study of the facilitation of respiration in myotonic dystrophy. Physiother Res Int. 2002;7:228–238
  113. Varelas PN, Chua HC, Natterman J, et al. Ventilatory care in myasthenia gravis crisis: assessing the baseline adverse event rate. Crit Care Med. 2002;30:2663–2668
  114. Wenneberg S, Gunnarsson LG, Ahlstrom G. Using a novel exercise programme for patients with muscular dystrophy (Part II: a quantitative study). Disabil Rehabil. 2004;26:595–602

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)01451-7

doi:10.1016/j.apmr.2007.07.024

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 11 , Pages 1452-1464, November 2007

Article Tools

* Image Usage & Resolution